These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2605778)

  • 1. Solidity of sickle hemoglobin gels: relevance to pathophysiology of sickling disorders.
    Danish EH; Harris JW; Oh K
    Cleve Clin J Med; 1989; 56(8):793-800. PubMed ID: 2605778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
    Brittenham GM; Schechter AN; Noguchi CT
    Blood; 1985 Jan; 65(1):183-9. PubMed ID: 3965046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hb A-like sickle haemoglobin: Hb S-providence.
    Gale RE; Blair NE; Huehns ER; Clegg JB
    Br J Haematol; 1988 Oct; 70(2):251-2. PubMed ID: 3191036
    [No Abstract]   [Full Text] [Related]  

  • 4. Sickle cell rheology is determined by polymer fraction--not cell morphology.
    Hiruma H; Noguchi CT; Uyesaka N; Hasegawa S; Blanchette-Mackie EJ; Schechter AN; Rodgers GP
    Am J Hematol; 1995 Jan; 48(1):19-28. PubMed ID: 7832188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hb S/Hb Lepore with mild sickling symptoms: a hemoglobin variant with mostly delta-chain sequences ameliorates sickle-cell disease.
    Fairbanks VF; McCormick DJ; Kubik KS; Rezuke WN; Black D; Ochaney MS; Schwartz D
    Am J Hematol; 1997 Feb; 54(2):164-5. PubMed ID: 9034293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered amount and activity of superoxide dismutase in sickle cell anemia.
    Schacter L; Warth JA; Gordon EM; Prasad A; Klein BL
    FASEB J; 1988 Mar; 2(3):237-43. PubMed ID: 3350236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for the sickle cell. I. Hemorheology and II. Microcalorimetry.
    Cerny LC; Cook FB; Stasiw DM
    Biorheology; 1974 Jul; 11(4):235-9. PubMed ID: 4447819
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes.
    Presley TD; Perlegas AS; Bain LE; Ballas SK; Nichols JS; Sabio H; Gladwin MT; Kato GJ; Kim-Shapiro DB
    Hemoglobin; 2010; 34(1):24-36. PubMed ID: 20113285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes.
    Monplaisir N; Merault G; Poyart C; Rhoda MD; Craescu C; Vidaud M; Galacteros F; Blouquit Y; Rosa J
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9363-7. PubMed ID: 3467311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell anemia as a rheologic disease.
    Horne MK
    Am J Med; 1981 Feb; 70(2):288-98. PubMed ID: 7008586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematological findings in 375 Sicilians with Hb S trait.
    Schilirò G; Comisi FF; Testa R; Dibenedetto SP; Samperi P; Marino S
    Haematologica; 1990; 75(2):113-6. PubMed ID: 2358201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of alpha thalassaemia in sickle cell trait patients by Hb-Bart's screening & quantitation of Hb-A & Hb-S.
    Misra RC
    Indian J Med Res; 1989 Dec; 90():459-62. PubMed ID: 2628314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. betaS Chain turnover in reticulocytes of sickle trait individuals with high or low concentrations of haemoglobin S.
    Shaeffer JR; Kleve LJ; DeSimone J
    Br J Haematol; 1976 Mar; 32(3):365-72. PubMed ID: 1252371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of red cell sickling. Effects of varying pH and of increasing intracellular hemoglobin concentration by osmotic shrinkage.
    Bookchin RM; Balazs T; Landau LC
    J Lab Clin Med; 1976 Apr; 87(4):597-616. PubMed ID: 5563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical diagnosis in sickle cell disease.
    Isaacs WA
    Ghana Med J; 1971 Mar; 10(1):40-3. PubMed ID: 5173734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
    Abraham EC; Stallings M; Abraham A; Garbutt GJ
    Biochim Biophys Acta; 1982 Jul; 705(1):76-81. PubMed ID: 7115734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise and hypoxia increase sickling in venous blood from an exercising limb in individuals with sickle cell trait.
    Martin TW; Weisman IM; Zeballos RJ; Stephenson SR
    Am J Med; 1989 Jul; 87(1):48-56. PubMed ID: 2741981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of glucose-6-phosphate dehydrogenase (G-6-PD) deficiency and sickle cell trait (Hb-AS).
    Nhonoli AM; Kujwalile JM; Kigoni EP; Masawe AE
    Trop Geogr Med; 1978 Mar; 30(1):99-101. PubMed ID: 675833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of sickle cell anemia.
    Bookchin RM; Lew VL
    Hematol Oncol Clin North Am; 1996 Dec; 10(6):1241-53. PubMed ID: 8956013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.